Role of high-mobility group box-1 protein in disruption of vascular barriers and regulation of leukocyte–endothelial interactions

References

• van Beijnum JR, Buurman WA, Griffioen AW. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 2008;11:91–9
   PubMed Web of Science ®Google Scholar
• Treutiger CJ, Mullins GE, Johansson AS, et al. High mobility group 1 B-box mediates activation of human endothelium. J Intern Med 2003;254:375–85
   PubMed Web of Science ®Google Scholar
• Fiuza C, Bustin M, Talwar S, et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003;101:2652–60
   PubMed Web of Science ®Google Scholar
• Chavakis E, Hain A, Vinci M, et al. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res 2007;100:204–12
   PubMed Web of Science ®Google Scholar
• Mitola S, Belleri M, Urbinati C, et al. Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J Immunol 2006;176:12–15
   PubMed Web of Science ®Google Scholar
• Agnello D, Wang H, Yang H, et al. HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine 2002;18:231–6
   PubMed Web of Science ®Google Scholar
• Kim JB, Sig Choi J, et al. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 2006;26:6413–21
   PubMed Web of Science ®Google Scholar
• Kawabata H, Setoguchi T, Yone K, et al. High mobility group box 1 is upregulated after spinal cord injury and is associated with neuronal cell apoptosis. Spine (Phila PA 1976) 2010;35:1109–15
   PubMed Web of Science ®Google Scholar
• Pedrazzi M, Raiteri L, Bonanno G, et al. Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein. J Neurochem 2006;99:827–38
   PubMed Web of Science ®Google Scholar
• Faraco G, Fossati S, Bianchi ME, et al. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. J Neurochem 2007;103:590–603
   PubMed Web of Science ®Google Scholar
• El-Asrar AM, Nawaz MI, Kangave D, et al. High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy. Mol Vis 2011;17:1829–38
   PubMed Web of Science ®Google Scholar
• Tang D, Kang R, Zeh HJ III, Lotze MT. High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal 2011;14:1315–35
   PubMed Web of Science ®Google Scholar
• Nogueira-Machado JA, Volpe CM, Veloso CA, Chaves MM. HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation. Expert Opin Ther Targets 2011;15:1023–35
   PubMed Web of Science ®Google Scholar
• Luan ZG, Zhang H, Yang PT, et al. HMGB1 activates nuclear factor-κB signaling by RAGE and increases the production of TNF-α in human umbilical vein endothelial cells. Immunobiology 2010;215:956–62
   PubMed Web of Science ®Google Scholar
• Wolfson RK, Chiang ET, Garcia JG. HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption. Microvasc Res 2011;81:189–97
   PubMed Web of Science ®Google Scholar
• Mohammad G, Siddiquei MM, Othman A, et al. High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina. Exp Eye Res 2013;107:101–9
   PubMed Web of Science ®Google Scholar
• Yang H, Wang H, Czura CJ, Tracey KJ. The cytokine activity of HMGB1. J Leukoc Biol 2005;78:1–8
   PubMed Web of Science ®Google Scholar
• Belgrano FS, de Abreu da Silva IC, Bastos de Oliveira FM, et al. Role of the acidic tail of high mobility group protein B1 (HMGB1) in protein stability and DNA bending. PLoS One 2013;8:e79572
   PubMed Web of Science ®Google Scholar
• Rouhiainen A, Kuja-Panula J, Wilkman E, et al. Regulation of monocyte migration by amphoterin (HMGB1). Blood 2004;104:1174–82
   PubMed Web of Science ®Google Scholar
• Tonnesen MG. Neutrophil-endothelial cell interactions: mechanisms of neutrophil adherence to vascular endothelium. J Invest Dermatol 1989;93:53S–8S
   PubMed Web of Science ®Google Scholar
• Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651–5
   PubMed Web of Science ®Google Scholar
• Urbonaviciute V, Fürnrohr BG, Meister S, et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008;205:3007–18
   PubMed Web of Science ®Google Scholar
• Santos AR, Dvoriantchikova G, Li Y, et al. Cellular mechanisms of high mobility group 1 (HMGB-1) protein action in the diabetic retinopathy. PLoS One 2014;9:e87574
   PubMed Web of Science ®Google Scholar
• Lotze MT, DeMarco RA. Dealing with death: HMGB1 as a novel target for cancer therapy. Curr Opin Investig Drugs 2003;4:1405–9
   PubMedGoogle Scholar
• Yang J, Huang C, Yang J, et al. Statins attenuate high mobility group box-1 protein induced vascular endothelial activation: a key role for TLR4/NF-κB signaling pathway. Mol Cell Biochem 2010;345:189–95
   PubMed Web of Science ®Google Scholar
• Kanellakis P, Agrotis A, Kyaw TS, et al. High-mobility group box protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol 2011;31:313–19
   PubMed Web of Science ®Google Scholar
• Mollica L, De Marchis F, Spitaleri A, et al. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem Biol 2007;14:431–41
   PubMed Web of Science ®Google Scholar
• Véliz LP, González FG, Duling BR, et al. Functional role of gap junctions in cytokine-induced leukocyte adhesion to endothelium in vivo. Am J Physiol Heart Circ Physiol 2008;295:H1056–66
   PubMed Web of Science ®Google Scholar
• Zheng QZ, Lou YJ. Pathologic characteristics of immunologic injury in primary cultured rat hepatocytes and protective effect of glycyrrhizin in vitro. Acta Pharmacol Sin 2003;24:771–7
   PubMed Web of Science ®Google Scholar
• Yuan H, Ji WS, Wu KX, et al. Anti-inflammatory effect of diammonium glycyrrhizinate in a rat model of ulcerative colitis. World J Gastroenterol 2006;12:4578–81
   PubMed Web of Science ®Google Scholar
• Kaji Y, Usui T, Ishida S, et al. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Invest Ophthalmol Vis Sci 2007;48:858–65
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Khosrof S, Bursell SE, et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA 1999;96:10836–41
   PubMed Web of Science ®Google Scholar
• Engelhardt B, Sorokin L. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol 2009;31:497–511
   PubMed Web of Science ®Google Scholar
• Cunha-Vaz JG. The blood-ocular barriers: past, present, and future. Doc Ophthalmol 1997;93:149–57
   PubMed Web of Science ®Google Scholar
• Labus J, Häckel S, Lucka L, Danker K. Interleukin-1β induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood-brain barrier model. J Neurosci Methods 2014;228C:35–45
   Web of Science ®Google Scholar
• Connell JJ, Chatain G, Cornelissen B, et al. Selective permeabilization of the blood-brain barrier at sites of metastasis. J Natl Cancer Inst 2013;105:1634–43
   PubMed Web of Science ®Google Scholar
• Walshe TE, Saint-Geniez M, Maharaj AS, et al. TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature. PLoS One 2009;4:e5149
   PubMed Web of Science ®Google Scholar
• Huang J, Liu B, Yang C, et al. Acute hyperglycemia worsens ischemic stroke-induced brain damage via high mobility group box-1 in rats. Brain Res 2013;1535:148–55
   PubMed Web of Science ®Google Scholar
• Antonetti DA, Barber AJ, Hollinger LA, et al. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem 1999;274:23463–7
   PubMed Web of Science ®Google Scholar
• Antonetti DA, Barber AJ, Khin S, et al. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 1998;47:1953–9
   PubMed Web of Science ®Google Scholar
• Fanning AS, Mitic LL, Anderson JM. Transmembrane proteins in the tight junction barrier. J Am Soc Nephrol 1999;10:1337–45
   PubMed Web of Science ®Google Scholar
• Matter K, Balda MS. Occludin and the functions of tight junctions. Int Rev Cytol 1999;186:117–46
   PubMed Web of Science ®Google Scholar
• Turksen K, Troy TC. Barriers built on claudins. J Cell Sci 2004;117:2435–47
   PubMed Web of Science ®Google Scholar
• Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003;161:653–60
   PubMed Web of Science ®Google Scholar
• Wittchen ES, Haskins J, Stevenson BR. Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J Biol Chem 1999;274:35179–85
   PubMed Web of Science ®Google Scholar
• Sumii T, Lo EH. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 2002;33:831–6
   PubMed Web of Science ®Google Scholar
• Parkkinen J, Rauvala H. Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J Biol Chem 1991;266:16730–5
   PubMed Web of Science ®Google Scholar
• Schiraldi M, Raucci A, Muñoz LM, et al. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J Exp Med 2012;209:551–63
   PubMed Web of Science ®Google Scholar
• Venereau E, Schiraldi M, Uguccioni M, Bianchi ME. HMGB1 and leukocyte migration during trauma and sterile inflammation. Mol Immunol 2013;55:76–82
   PubMed Web of Science ®Google Scholar
• Yang H, Antoine DJ, Andersson U, Tracey KJ. The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukoc Biol 2013;93:865–73
   PubMed Web of Science ®Google Scholar
• Huttunen HJ, Fages C, Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999;274:19919–24
   PubMed Web of Science ®Google Scholar
• Huttunen HJ, Rauvala H. Amphoterin as an extracellular regulator of cell motility: from discovery to disease. J Intern Med 2004;255:351–66
   PubMed Web of Science ®Google Scholar
• Taguchi A, Blood DC, del Toro G, et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000;405:354–60
   PubMed Web of Science ®Google Scholar
• Borbiev T, Birukova A, Liu F, et al. p38 MAP kinase-dependent regulation of endothelial cell permeability. Am J Physiol Lung Cell Mol Physiol 2004;287:L911–18
   PubMed Web of Science ®Google Scholar
• Garcia JG, Wang P, Schaphorst KL, et al. Critical involvement of p38 MAP kinase in pertussis toxin-induced cytoskeletal reorganization and lung permeability. FASEB J 2002;16:1064–76
   PubMed Web of Science ®Google Scholar
• Ishihara K, Tsutsumi K, Kawane S, et al. The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site. FEBS Lett 2003;550:107–13
   PubMed Web of Science ®Google Scholar
• Yan SD, Schmidt AM, Anderson GM, et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 1994;269:9889–97
   PubMed Web of Science ®Google Scholar
• Park JS, Arcaroli J, Yum HK, et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 2003;284:C870–9
   PubMed Web of Science ®Google Scholar
• Huang W, Liu Y, Li L, et al. HMGB1 increases permeability of the endothelial cell monolayer via RAGE and Src family tyrosine kinase pathways. Inflammation 2012;35:350–62
   PubMed Web of Science ®Google Scholar
• Kim ID, Shin JH, Kim SW, et al. Intranasal delivery of HMGB1 siRNA confers target gene knockdown and robust neuroprotection in the postischemic brain. Mol Ther 2012;20:829–39
   PubMed Web of Science ®Google Scholar
• Kim ID, Lim CM, Kim JB, et al. Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain. J Contr Rel 2010;142:422–30
   PubMed Web of Science ®Google Scholar
• Zhang J, Takahashi HK, Liu K, et al. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 2011;42:1420–8
   PubMed Web of Science ®Google Scholar
• Liu K, Mori S, Takahashi HK, et al. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J 2007;21:3904–16
   PubMed Web of Science ®Google Scholar
• Yang EJ, Ku SK, Lee W, et al. Barrier protective effects of rosmarinic acid on HMGB1-induced inflammatory responses in vitro and in vivo. J Cell Physiol 2013;228:975–82
   PubMed Web of Science ®Google Scholar
• Ku SK, Lee IC, Kim JA, Bae JS. Anti-septic effects of pellitorine in HMGB1-induced inflammatory responses in vitro and in vivo. Inflammation. 2014;37:338–48
   PubMed Web of Science ®Google Scholar
• Yoo H, Ku SK, Han MS, et al. Anti-septic effects of fisetin in vitro and in vivo. Inflammation 2014;37:1560–74
   Google Scholar
• Lee W, Ku S, Yoo H, et al. Andrographolide inhibits HMGB1-induced inflammatory responses in human umbilical vein endothelial cells and in murine polymicrobial sepsis. Acta Physiol (Oxf) 2014;211:176–87
   PubMed Web of Science ®Google Scholar
• Yoo H, Ku SK, Baek YD, Bae JS. Anti-inflammatory effects of rutin on HMGB1-induced inflammatory responses in vitro and in vivo. Inflamm Res 2014;63:197–206
   PubMed Web of Science ®Google Scholar
• Zhou H, Ji X, Wu Y, et al. A dual-role of Gu-4 in suppressing HMGB1 secretion and blocking HMGB1 pro-inflammatory activity during inflammation. PLoS One 2014;9:e89634
   PubMed Web of Science ®Google Scholar
• Iba T, Aihara K, Watanabe S, et al. Recombinant thrombomodulin improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat LPS model. Thromb Res 2013;131:295–9
   PubMed Web of Science ®Google Scholar